SCHEMBL1723568

SCHEMBL1723568

CC(C(=O)O)(C1=CCC(=O)C=C1)C1=CCC(=O)C=C1.P=NP

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL10482361 0.74
SCHEMBL12038679 0.69 CES2 (0.35)
Terephthalic Acid SCHEMBL6535714 0.68 RXRA (0.40)
SCHEMBL2772030 0.64
SCHEMBL1723525 0.62 EGFR (0.33)
SCHEMBL13122485 0.62 GSK3A (0.33)
SCHEMBL10589783 0.61
SCHEMBL9842155 0.61 ESR2 (0.43)
SCHEMBL29156179 0.59 GABRA1 (0.50)
SCHEMBL12038664 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3852801-A1 MUCOADHESIVE LIPIDIC DELIVERY SYSTEM University of Saskatchewan (CA) 2021-07-28 EP claimed
WO-2020056524-A1 MUCOADHESIVE LIPIDIC DELIVERY SYSTEM UNIVERSITY OF SASKATCHEWAN (CA) 2020-03-26 WO claimed
US-20180344836-A1 METHODS FOR TREATING, PREVENTING AND DIAGNOSING PORCINE EPIDEMIC DIARRHEA VIRUS INFECTION UNIVERSITY OF SASKATCHEWAN (CA) 2018-12-06 US claimed
EP-3380494-A1 METHODS FOR TREATING, PREVENTING AND DIAGNOSING PORCINE EPIDEMIC DIARRHEA VIRUS INFECTION The University of Saskatchewan (CA) 2018-10-03 EP claimed
WO-2017088060-A1 METHODS FOR TREATING, PREVENTING AND DIAGNOSING PORCINE EPIDEMIC DIARRHEA VIRUS INFECTION UNIVERSITY OF SASKATCHEWAN (CA) 2017-06-01 WO claimed
US-9408908-B2 Combination adjuvant formulation UNIV SASKATCHEWAN (CA) 2016-08-09 US claimed
EP-2344522-B1 COMBINATION ADJUVANT FORMULATION UNIV SASKATCHEWAN (CA) 2016-01-27 EP claimed
US-9061001-B2 Combination adjuvant formulation UNIVERSITY OF SASKATCHEWAN (CA) 2015-06-23 US claimed
US-20140248313-A1 COMBINATION ADJUVANT FORMULATION UNIVERSITY OF SASKATCHEWAN (CA) 2014-09-04 US claimed
EP-2344522-A1 COMBINATION ADJUVANT FORMULATION The University of Saskatchewan (CA) 2011-07-20 EP claimed
US-20100239611-A1 Combination adjuvant formulation INTERNATIONAL VACCINE INSTITUTE (KR) 2010-09-23 US claimed
WO-2010043039-A1 COMBINATION ADJUVANT FORMULATION UNIVERSITY OF SASKATCHEWAN (CA) 2010-04-22 WO claimed
US-20240197865-A1 COMPOSITIONS AND METHODS FOR PREVENTING RSV AND PIV3 INFECTIONS UNIVERSITY OF SASKATCHEWAN (CA) 2024-06-20 US disclosed
US-20240199663-A1 Cyclopolyphosphazenes, Related Methods of Preparation and Methods of Use UNITED STATES DEPARTMENT OF ENERGY 2024-06-20 US disclosed
US-20240066111-A1 LAWSONIA INTRACELLULARIS COMPOSITIONS AND METHODS OF USING THE SAME UNIV SASKATCHEWAN (CA) 2024-02-29 US disclosed
EP-4326781-A1 COMPOSITIONS AND METHODS FOR PREVENTING RSV AND PIV3 INFECTIONS University of Saskatchewan (CA) 2024-02-28 EP disclosed
US-20140248313-A1 COMBINATION ADJUVANT FORMULATION UNIVERSITY OF SASKATCHEWAN (CA) 2014-09-04 US disclosed
EP-2344522-A1 COMBINATION ADJUVANT FORMULATION The University of Saskatchewan (CA) 2011-07-20 EP disclosed
US-20100239611-A1 Combination adjuvant formulation INTERNATIONAL VACCINE INSTITUTE (KR) 2010-09-23 US disclosed
WO-2010043039-A1 COMBINATION ADJUVANT FORMULATION UNIVERSITY OF SASKATCHEWAN (CA) 2010-04-22 WO disclosed